Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response

[1]  T. Messer,et al.  Therapieresistente Depressionen , 2009, Fortschritte der Neurologie-Psychiatrie.

[2]  H. Neels,et al.  Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. , 1996, Journal of affective disorders.

[3]  V. Arolt,et al.  Major depressive disorder is associated with elevated monocyte counts , 1996, Acta psychiatrica Scandinavica.

[4]  H. Neels,et al.  Lower Serum L-Tryptophan Availability in Depression as a Marker of a More Generalized Disorder in Protein Metabolism , 1996, Neuropsychopharmacology.

[5]  J. Rybakowski,et al.  Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder. , 1996, Journal of affective disorders.

[6]  B. Woodward,et al.  The CD4/CD8 ratio in the blood does not reflect the response of this index in secondary lymphoid organs of weanling mice in models of protein-energy malnutrition known to depress thymus-dependent immunity. , 1996, The Journal of nutrition.

[7]  S. Young,et al.  L-Tryptophan: Biochemical, nutritional and pharmacological aspects , 1996, Amino Acids.

[8]  M. Bekaroǧlu,et al.  Polymorphonuclear (PMN) elastase levels in depressive disorders , 1996, Biological Psychiatry.

[9]  M. Maes,et al.  The monocyte-T-lymphocyte hypothesis of major depression , 1995, Psychoneuroendocrinology.

[10]  H. Meltzer,et al.  Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. , 1995, Journal of affective disorders.

[11]  N. Müller.  Psychoneuroimmunology: Implications for the Drug Treatment of Psychiatric Disorders , 1995 .

[12]  J. Rybakowski,et al.  Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine , 1995, Annals of the New York Academy of Sciences.

[13]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  H. Meltzer,et al.  Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response , 1994, Psychiatry Research.

[15]  A. Sluzewska,et al.  Haptoglobin levels in a chronic mild stress model of depression in rats before and after treatment , 1994, European Neuropsychopharmacology.

[16]  M. D. de Broe,et al.  Hypozincemia in depression. , 1994, Journal of affective disorders.

[17]  D. Straus,et al.  Effect of amino acid limitation on the expression of 19 genes in rat hepatoma cells , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  B. Leonard,et al.  Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. , 1994, Journal of affective disorders.

[19]  M. Walser,et al.  Free and protein-bound tryptophan in serum of untreated patients with chronic renal failure. , 1993, Kidney international.

[20]  H. Meltzer,et al.  Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression , 1993, Psychiatry Research.

[21]  H. Meltzer,et al.  Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression , 1993, Psychiatry Research.

[22]  H. Meltzer,et al.  Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? , 1993, The American journal of psychiatry.

[23]  Margaret Der,et al.  Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients , 1992, Journal of Neuroimmunology.

[24]  G. Aghajanian,et al.  Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients , 1992, Journal of Chemical Neuroanatomy.

[25]  R. Flanigan,et al.  Oxidative tryptophan metabolism in renal allograft recipients: increased kynurenine synthesis is associated with inflammation and OKT3 therapy. , 1992, Cytokine.

[26]  M. Banay‐Schwartz,et al.  Plasma tryptophan to large neutral amino acid ratios in depressed and normal subjects. , 1990, Journal of affective disorders.

[27]  P. Blockx,et al.  The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients. , 1990, Journal of affective disorders.

[28]  L. Moldawer,et al.  Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. , 1987, Clinical physiology.

[29]  S. Møller.  Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments , 1985, Acta psychiatrica Scandinavica. Supplementum.

[30]  G. Curzon,et al.  Tryptophan Transport to the Brain: Newer Findings and Older Ones Reconsidered , 1984 .

[31]  O. Hayaishi,et al.  The Relationship between Plasma Kynurenine and Indoleamine 2,3-Dioxygenase Activity in the Extrahepatic Tissues , 1984 .

[32]  J. Fernstrom.  Tryptophan Availability and Serotonin Synthesis in Rat Brain: Effects of Experimental Diabetes , 1984 .

[33]  H. Hendrie,et al.  Plasma tryptophan and five other amino acids in depressed and normal subjects. , 1981, Archives of general psychiatry.

[34]  W. Pardridge.  Tryptophan transport through the blood-brain barrier: in vivo measurement of free and albumin-bound amino acid. , 1979, Life sciences.

[35]  W. Oldendorf,et al.  EFFECT OF ALBUMIN BINDING AND AMINO ACID COMPETITION ON TRYPTOPHAN UPTAKE INTO BRAIN 1 , 1977, Journal of neurochemistry.

[36]  D. Murphy,et al.  Dietary regulation of brain tryptophan metabolism by plasma ratio of free tryptophan and neutral amino acids in humans , 1974, Nature.

[37]  I. Blackburn,et al.  Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness , 1973, Psychological Medicine.

[38]  D. Eccleston,et al.  THE EFFECTS OF PRECURSOR LOADING IN THE CEREBRAL METABOLISM OF 5‐HYDROXYINDOLES , 1968, Journal of neurochemistry.

[39]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[40]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[41]  J. Oncley,et al.  The specific binding of L-tryptophan to serum albumin. , 1958, The Journal of biological chemistry.

[42]  J. Deakin,et al.  A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation , 2005, Psychopharmacology.

[43]  S. Møller,et al.  Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline , 2004, Psychopharmacology.

[44]  R. Pihl,et al.  A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males , 2004, Psychopharmacology.

[45]  R. Pihl,et al.  Tryptophan depletion causes a rapid lowering of mood in normal males , 2004, Psychopharmacology.

[46]  N. Varney,et al.  Psychopharmacology: The Fourth Generation of Progress. , 1996 .

[47]  V. Arolt,et al.  Increased CD56+ natural killer cells and related cytokines in major depression. , 1996, Clinical immunology and immunopathology.

[48]  E. Smeraldi,et al.  Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor. , 1994, Neuropsychobiology.

[49]  H. Meltzer,et al.  Evidence for the existence of major depression with and without anxiety features. , 1994, Psychopathology.

[50]  H. Meltzer,et al.  Haptoglobin phenotypes and gene frequencies in unipolar major depression. , 1994, The American journal of psychiatry.

[51]  B. Leonard,et al.  An acute phase protein response in the olfactory bulbectomised rat : effect of sertraline treatment , 1994 .

[52]  J. Calabrese,et al.  Relationships between lower plasma L-tryptophan levels and immune variables in depression , 1993 .

[53]  E. Werner,et al.  Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. , 1990, Journal of acquired immune deficiency syndromes.

[54]  S. Rapoport,et al.  Influence of cerebral blood flow on tryptophan uptake into brain , 1990 .

[55]  D. Charney,et al.  Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. , 1989, Life sciences.

[56]  B. Leonard,et al.  Monoamine-related markers of depression: changes following treatment. , 1982, Journal of psychiatric research.